Home > Boards > US OTC > Cannabis >

Fiore Cannabais Ltd. (FIORF)

FIORF RSS Feed
Add FIORF Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 4/13/2021 3:31:11 AM - Followers: 71 - Board type: Free - Posts Today: 0

Fiore Cannabis Sells Surplus Cannabis Licence
to Fund Expansion of Apex Cultivation Facility

 
FIOR News Release
March 31, 2021
 
Kelowna, British Columbia — Fiore Cannabis (CSE:FIOR) (OTCQX:FIORF) (“Fiore” or the “Company”), a licensed multi-state cannabis cultivator, producer and retailer, today announced that it has signed a Definitive Agreement to sell, through a wholly owned subsidiary, a surplus cultivation license for its Apex cannabis cultivation and production facility in Las Vegas, Nevada to Allied Corp. (OTCQB:ALID) (“Allied”) for US$1.5 million. Allied is a company actively increasing its involvement in the international cannabis space.
“We are building a great partnership with the team at Allied as we work collaboratively to drive our business plan forward. Selling this surplus licence advances us along our strategic path. The funds generated mean we can push forward on our expansion program for our Apex facility in Las Vegas to enhance cultivation capacity and deliver additional cannabis products into the growing and high-margin Nevada market,” said Erik Anderson, President and CEO of Fiore Cannabis.
Calum Hughes, CEO of Allied, said: “We see great opportunity in acquiring this licence from Fiore and building out our own facilities to serve local medical markets. We look forward to working with their team and have them assist us in operating the new facility. Fiore is the perfect partner which also sees the potential massive opportunity that U.S. legalization presents.”
 
A revenue-sharing agreement for incremental sales from the facility has been negotiated between the parties. Fiore will be assisting Allied with the genetics and selection of cannabis strains for their new operation as well as consulting on the marketing of eventual cannabis products through Fiore’s already established medical and retail partnerships.
 
Fiore is preparing to apply the proceeds from this sale to its expansion program for its own Apex facility which sits on a seven-acre parcel of land. A significant increase of cultivation and production space from 10,000 square feet to approximately 80,000 square feet is being planned at this time. The Company has developed strong relationships with the Nevada retail market for distribution of additional product as Fiore’s award-winning organic cannabis product is in high demand.
 
About Fiore Cannabis
Fiore Cannabis (CSE:FIOR) (OTCQX:FIORF) is a publicly traded company that has been investing in the development of medical and recreational cannabis products since 2014. Fiore has expanded its operating portfolio to include cultivation, production and retail offerings in our key North American legal jurisdictions of Nevada and California. For more information, please visit www.fiorecannabis.com.
 
For Further Information
Erik Anderson, President and CEO
1-877-438-5448 Ext. 713
eanderson@fiorecannabis.com



Check out the latest video from Erik Anderson of Fiore

https://youtu.be/Qc1oYQ9bUhc

Join the telegram conversation at:

https://t.me/fiorecannabis

Join the Youtube Channel 

https://www.youtube.com/channel/UCIvF1YOeIwEi9OT__sdcC9g


Fiore Cannabis Announces Sale of Surplus Cannabis Licence to Fund Expansion of Apex Cultivation Facility
FIOR News Release
February 16, 2021

Kelowna, British Columbia — Fiore Cannabis (CSE:FIOR) (OTCQX:FIORF) (“Fiore” or the “Company”), a licensed multi-state cannabis cultivator, producer and retailer, today announced that it has signed a non-binding Letter of Intent on February 15, 2021 to sell, through a wholly owned subsidiary, a surplus cultivation license for its Apex cannabis cultivation and production facility in Las Vegas, Nevada to Allied Corp. (OTCQB:ALID) (“Allied”) for US$1.5 million. A definitive agreement is expected to follow within 30 days. Allied is a company actively increasing its involvement in the international medical and speciality cannabis space.

“The licence sale we are negotiating with Allied pushes us further along our strategic path. We expect to work creatively and effectively with Allied’s CEO Calum Hughes and his team to make the licence productive and generate benefits for both companies. Funds from this sale can enable Fiore to speed up the expansion program for our Apex facility to enhance cultivation capacity and deliver additional cannabis products into the growing and high-margin Nevada market,” said Erik Anderson, President and CEO of Fiore Cannabis.

The two companies have developed initial terms that will see them working together as Allied constructs a facility which Fiore would then operate in partnership. A revenue-sharing agreement for incremental sales from the facility will be negotiated between the parties. Due to its expertise, Fiore will be assisting with the genetics and selection of cannabis strains for the Allied operation as well as consulting on the marketing of eventual cannabis products through Fiore’s already established medical and retail partnerships.

Fiore plans to apply the proceeds from this sale to its expansion program for the Apex facility. A significant increase of cultivation space is being considered at this time. Earlier this month, the Company reported successful crop results in January for the current footprint of the site which were sold immediately into the Nevada retail market.

Fiore Cannabis Continues Strategic Program to Refocus on Core Assets
 
FIOR News Release
February 11, 2021
 
Kelowna, British Columbia — Fiore Cannabis (CSE:FIOR) (OTCQX:FIORF) (“Fiore” or the “Company”), a licensed multi-state cannabis cultivator, producer and retailer, today announced that it continues to aggressively pursue its program to refocus on core assets in the key operating markets of Nevada and California. The Company recently noted these operations helped it achieve positive Adjusted EBITDA for the month of January.
“We have been able to adapt our company in the past year and get focused on where we can best operate, produce top-quality cannabis product, and serve growing markets. We have an approach to the cultivation, production and retail of cannabis at Fiore that is all about top-quality products, strong branding and generating solid financial returns,” said Erik Anderson, President and CEO of Fiore Cannabis.
Anderson noted the Company is focused on the assets that can deliver strong revenue and margins and thus why its focus has been narrowed to Nevada and California. Recent corporate developments for the Company support this focus as they include the sale of an asset in Lynden, Washington and a letter of intent reached to sell an underperforming asset in Celista, British Columbia. The Celista sale, announced originally in mid-2020, is currently in final stages with an announcement expected in the coming month.
 
"It’s an easy decision to divest assets in Washington and British Columbia and to focus tightly on our core assets. We have opportunities in Nevada and California to expand our footprint and become more vertically integrated. As an example, we are achieving very successful crops from our Apex cultivation and production facility in North Las Vegas as evidenced by recent results. We’re currently working with a 10,000 square foot facility sitting on seven acres of property. So we’re considering now how we’ll expand the facility to boost production further to serve the growing customer base in the Nevada market. We’ll plan to do that smartly and in a way that does not dilute our shareholders,” said Anderson.
 
The Company holds a surplus cultivation licence for the Apex facility which can be sold to help fund expansion of the site.
 
About Fiore Cannabis
Fiore Cannabis (CSE:FIOR) (OTCQX:FIORF) is a publicly traded company that has been investing in the development of medical and recreational cannabis products since 2014. Fiore has expanded its operating portfolio to include cultivation, production and retail offerings in our key North American legal jurisdictions of Nevada and California. For more information, please visit www.fiorecannabis.com.


February 9, 2021

Fiore Cannabis Announces Positive Adjusted EBITDA and Successful Organic Cannabis Crop Results for January

Kelowna, British Columbia — Fiore Cannabis (CSE:FIOR) (OTCQX:FIORF) (“Fiore” or the “Company”), a licensed multi-state Cannabis cultivator, producer and retailer, today announced that it achieved a positive Adjusted EBITDA for the month of January and reported ongoing crop results for its flagship cannabis cultivation facility. The Company is achieving a premium position amongst cultivators due to its flower product being organically grown and boasting high THC levels.

The Company achieved the positive Adjusted EBITDA in January from a profit margin of 25% on gross revenues of approximately $360,000.
“We had committed to clarifying our financial picture and delivering positive Adjusted EBITDA in early 2021. Doing so for the month of January is a testament to the strong management of our assets and the ongoing efforts of our staff. Our crop performance in January was also just excellent and bodes well for continued strong operating results through the year,” said Erik Anderson, President and CEO of Fiore Cannabis.

The two crops sold in January were the first achieved under newly implemented organic living soil growing conditions at the Apex cultivation and production facility in North Las Vegas, Nevada. The result has been high yield, high THC cannabis flower that meets premium quality requirements. The facility’s proximity to the Las Vegas recreational and medical cannabis market ensures multiple sales avenues for Fiore product. Even with pandemic restrictions, Nevada remains one of the country’s most lucrative markets and its tourism focus is projected to increase demand for cannabis products as restrictions are decreased over time.

“The Fiore cultivation team can be very proud of the quality organic cannabis product we are delivering into the market and the recognition this generates for us. The financial results in January are based on two crops being harvested and sold into the market. We expect February and future months will include an equivalent or greater number of crops being harvested and available for sale each month. We receive premium pricing for this cannabis product as we continue to build our name as a top quality cultivator. That translates into both strong demand for our product and high margin on our sales,” said Anderson.

February 4, 2021

Kelowna, British Columbia—Fiore Cannabis (CSE:FIOR) (OTCQX:FIORF) (“Fiore” or “the Company”), a licensed multi-state Cannabis cultivator, producer and retailer, today announced that the date for its Annual General Meeting (AGM) will be April 20, 2021 with the meeting expected to be held as a virtual video conference. The Company will celebrate the special 4/20 day in the cannabis space by sharing an update on its business plan and growth strategy with investors.

The Company also announced it has changed its fiscal year-end from March 31 to December 31, meaning that its 2020 consolidated financial results ending on December 31, 2020 will be released on or before April 30, 2021.

“We changed the year end to align our reporting period with the calendar year,” said Erik Anderson, Fiore’s President and CEO. “Aligning our fiscal year to the calendar makes more sense, especially with regards to financial modelling and forecasting.”

As a sign of continued progress towards sound business fundamentals and improving investor confidence, Fiore is also pleased to confirm that the convertible debenture interest payment, which was extended in cooperation with investors from October 23, 2020 to January 23, 2021, was made on time by way of a cash payment.

“We really appreciate the support and cooperation of our investors in this group,” Anderson noted. “They understand we are making progress towards turning the company around to profitability so it was nice to return that goodwill by ensuring we made the interest payment on time.”

The company’s cultivation facility in Las Vegas saw three harvests come down in January and sold the first two organic crops of 2021 to local dispensaries immediately upon packaging. Strong yields and high THC percentages were achieved, and the cultivation team expects that testing results will get even stronger over the year as its “living soil” protocols mature. Fiore also continues to see revenues grow at its dispensary, Green Leaf Wellness, in Desert Hot Springs, which posted another operational cash-flow positive result for January due to decreases in payroll costs, working with vendors for preferred pricing and increasing delivery customers.

About Fiore Cannabis Fiore Cannabis (CSE:FIOR) (OTCQX:FIORF) is a publicly traded company that has been investing in the development of medical and recreational cannabis products since 2014. Fiore has expanded its operating portfolio to include cultivation, production and retail offerings in our key North American legal jurisdictions of Nevada, California, Washington and British Columbia. For more information, please visit www.fiorecannabis.com.


January 22, 2021

New addition to the YouTube Channel:

https://youtu.be/dDeoWAzfzr0




Newsfile Corp.
Tue., January 12, 2021, 5:02 a.m. MST
 
 
"" rel="nofollow" target="_blank">https://www.newsfilecorp.com/newsinfo/71776/202"; style="animation:100ms ease 0s 1 normal none running fade; border-radius:8px; border:none; height:auto; left:359.547px; max-width:100%; min-height:1px; position:absolute; top:0.5px; transform:translate(-50%, -50%); vertical-align:bottom; width:1px">

Kelowna, British Columbia--(Newsfile Corp. - January 12, 2021) - Fiore Cannabis Ltd. (CSE: FIOR) (OTCQX: FIORF) ("Fiore" or "Company"), a licensed multi-state Cannabis cultivator, producer and retailer, today released a corporate update to investors, highlighting recent company developments and updating the Company's strategic plan heading into 2021.

Key highlights:

- Fiore's Share Price increased 13% in 2020 and was up 116% (from 9 cents to 19.5 cents) since the name change to Fiore Cannabis Ltd.;
- Revenues for Green Leaf Wellness, Fiore's dispensary in Desert Hot Springs, California, were up 22% year-over-year;
- Inventory for Fiore's Apex cultivation and production facility in Las Vegas currently sits at 60 pounds of dry 100% organically soil-grown flower, 77 pounds of trim, 287 pounds of fresh frozen biomass and 4.4 pounds of distillate;
- Operating expenses for the company decreased by 34% in 2020 compared to 2019;
- Company raised more than $2.2mm CAD from two Private Placements in 2020;
- Company secured $2mm USD loan as a private mortgage secured against US assets;
- Work continued uninterrupted within the global pandemic brought on by COCID-19 as Fiore's operations in Nevada and California were deemed essential services;
- Returned 18.5-million shares to treasury by unwinding the merger with ACC Enterprises;
- Crossed more than 10-million shares to insiders to address sell-side pressure on the CSE;
- Insiders and investors know to management equal approximately 80% of the 133-million issued and outstanding shares;
- US election of Biden/Harris and the Georgia Senate runoff going to the Democratic Party have combined to open the door to cannabis-friendly legislation in the form of the MORE Act, the SAFE Banking Act and the STATES Act.

Fiore enters the 2021 fiscal year with a great deal of market momentum. At the Apex facility, three flower harvests will be packaged and ready for sale to the Nevada market in late January. Three more harvests will follow in February and two more in March. Fiore is also processing all its crude extracts into live resin distillate ready for vape cartridges that will be marketed under their Diamante brand. Additional brands have been created to bring specialty extracts and concentrate products to market in Nevada.

The global pandemic brought on by COVID-19 has not posed a serious threat to Fiore's operations thanks to the immediate safety protocols put into place at the beginning of the outbreak. As the company moves into 2021, Fiore will continue its forward momentum by focusing to perfect the business model for Apex in Nevada and its retail dispensary in California.

About Fiore Cannabis Ltd.
Fiore Cannabis Ltd. (CSE: FIOR) (OTCQX: FIORF) is a publicly traded company that has been investing in the development of medical and recreational cannabis products since 2014. Fiore has expanded its operating portfolio to include cultivation, production and retail offerings in our key North American legal jurisdictions Nevada, California and British Columbia. For more information, please visit 
www.fiorecannabis.com

For Further Information:
Erik Anderson, President and CEO
1-877-438-5448 Ext. 713
eanderson@fiorecannabis.com

Cannabis Industry Involvement:

The Company owns marijuana licenses in California and Nevada. Marijuana is legal in each state; however, marijuana remains illegal under United States federal law and the approach to enforcement of U.S. federal law against marijuana is subject to change. Shareholders and investors need to be aware that federal enforcement actions could adversely affect their investments and that the Company's ability to support continuing U.S.-based operations and its access private and public capital could be materially adversely affected.

Forward-Looking Statements:
This news release contains forward-looking statements or information that relate to our current expectations and views of future events, including in respect of the closing of the fourth tranche, the use of proceeds, any extension of the Maturity Date and increases regarding the size of the Debenture offering. These statements relate to future events or future performance. Statements which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, outlook, expectations or intentions regarding the future including words or phrases such as "anticipate", "objective", "may", "will", "might", "should", "could", "can", "intend", "expect", "believe", "estimate", "predict", "potential", "plan", "is designed to", "project", "continue", or similar expressions suggest future outcomes or the negative thereof or similar variations. Forward-looking statements may also include, among other things, statements about the future business strategy; expectations of obtaining licenses and permits; expectations regarding expenses, sales and operations; future customer concentration; anticipated cash needs and estimates regarding capital requirements and the need for additional financing; total processing capacity; the ability to anticipate the future needs of customers; plans for future products and enhancements of existing products; future growth strategy and growth rate; future intellectual property; changes in laws and regulations; regulatory approvals and other matters; and anticipated trends and challenges in the markets in which the Company may operate.

These forward-looking statements are based on the Company's current projections and expectations about future events and financial trends that management believes might affect its financial condition, results of operations, business strategy and financial needs, and on certain assumptions and analysis made by the Company in light of the experience and perception of historical trends, current conditions and expected future developments and other factors management believes are appropriate.

Forward-looking information and statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking information and statements herein. Such factors include, among others: the risks and uncertainties identified in the Company's reports and filings with the applicable Canadian securities regulators. Although the Company believes that any forward-looking information and statements herein are reasonable, in light of the use of assumptions and the significant risks and uncertainties inherent in such information and statements, there can be no assurance that any such forward-looking information and statements will prove to be accurate, and accordingly readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance upon such forward-looking information and statements. Any forward-looking information and statements herein are made as of the date hereof, and except as required by applicable laws, the Company assumes no obligation and disclaims any intention to update or revise any forward-looking information and statements herein or to update the reasons that actual events or results could or do differ from those projected in any forward looking information and statements herein, whether as a result of new information, future events or results, or otherwise, except as required by applicable law.

 

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/71776





NEW WEBSITE AND NAME CHANGE EFFECTIVE NOVEMBER 10, 2020

www.fiorecannabis.com

NEW symbol in Canada FIOR:CSE  USA is FIORF:OTC




CITATION GROWTH CORP. RELEASES LETTER FROM CEO

Citation Growth Corp. has released a letter from Erik Anderson, president and chief executive officer, discussing the COVID-19 pandemic and recent company developments.

To our shareholders:

I am following up on the state of the nation communique that was sent out in March, 2020, to highlight our progress of turning Citation Growth around toward profitability over the past two quarters.

The global pandemic brought on by COVID-19 has been challenging in the sense that typical personal interactions and business travel related to running a company essentially came to a halt in mid-March. Our Q1 (from April to June 30) was easily the most challenging period of time during my 28-year career. That said, our operations in Nevada and California were both classified as essential services; and, with protective measures to combat COVID-19 being put in place immediately, we continued to cultivate at our north Las Vegas facility (Apex) and sell products to patients and customers at our dispensary in Desert Hot Springs, Green Leaf Wellness (GLW).

Our corporate team in Canada was also extremely productive during this quarter and we were able to complete some important transitional achievements, namely:

 

  • Adding cannabis industry veteran, Shane Dungey, to our board of directors;
    Signing the LOI to sell our Celista, B.C., asset to Indigenomix;
    Hosting our virtual AGM (annual general meeting) on April 23;
    Installing new LED lights at our Apex facility and implementing the proprietary organic growing methodology from our multigeneration grow team in Canada;
    Implementing operational efficiencies and cost reduction measures to streamline both revenue generating operations in Nevada and California, which will make both more profitable over the long term;
    Selling our Washington State asset in Lynden, Wash., to clean up our balance sheet;
    Closing our non-brokered private placement for more than $1-million.

 

As we moved into our Q2 (July to Sept. 30), we continued our forward momentum by focusing on perfecting the business model for Apex and GLW. Both operations are close to cash flow positive and our corporate team is laser focused on achieving this goal in early 2021. Other notable achievements since July 1 include the following:

 

  • Appointed Calgary businessman and former NHL athlete, Ron Stern, to our board of directors;
    Signed the definitive agreement with Indigenomix to confirm the sale of our Celista, B.C., asset;
    Posted our fourth quarter and 2019 year-end financials and management's discussion and analysis on SEDAR (Sept. 11);
    Closed the first tranche of a private placement debenture with PI Financial on Aug. 20 for gross proceeds of $780,000;
    Settled with ACC Enterprises to effectively reverse the 2019 merger, part ways and deconsolidate ACC from the company's consolidated financial statements;
    Signed two letters of intent to vend in a B.C. microcultivation based in Vernon (Laughing Turtle Farms) as well as two retail stores in the BC Okanagan Valley, essentially making Citation a vertically integrated player in the B.C. market and primed to capitalize on the forthcoming direct delivery and farm gate initiatives;
    Appointed U.S. businessman, Dylan Rexing, to our board of directors;
    Hired a new master grower for Apex and have three additional top Nevada growers set to join the cultivation team soon.

 

Despite the tough times for business, we feel we are making all the right moves and have a great team. We have also been tracking the U.S. election and feel that legislative change could be on the horizon in several forms: 1) approving the Safe Banking Act (already passed in the U.S. House of Representatives), 2) federal decriminalization (the Biden/Harris ticket is on the record in favour), 3) continued state legalization for both medical and adult recreational use (five more states vote for legalization on Nov. 3) and 4) an investor community frothing to jump into a decriminalized national industry similar to what we saw in Canada once federal legalization was announced. While our business plan does not hinge on U.S. decriminalization, it appears that the U.S. cannabis industry is being looked upon as a new source of revenue that will contribute to the post-COVID-19 economic stimulus plan, the Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act. Any forward momentum in this regard will be very positive for our business.

Since our goal is to be a premium multistate operator governed by sound business fundamentals, I recently travelled to the U.S. to review our operations in person. Here is an update from Nevada and California.

North Las Vegas -- Apex

 

  • All our grow rooms are now installed with Fluence LED lights, replacing the failing HPS lights that have been returned for warranty replacement (and sale on the open market).
    We have implemented an enhanced organic living soil platform throughout the facility, which will result in much greater yields and even higher THC (tetrahydrocannabinol) percentages for our flower.
    Our new master grower has been instrumental in not only bringing in a new cultivation team to work with our living soil platform, but he has also thoroughly gone over each component of the Apex facility. His findings indicated that routine maintenance of the HVAC (heating, ventilation and air conditioning) and R/O water system was badly overdue and so a complete overhaul of both systems was put in place immediately. The facility is now running more efficiently and optimal for the type of high THC plants we will cultivate.
    We established new partnerships with local production operators, THC Productions and Taproot. With all of our harvests from February to September being stored as fresh frozen inventory, we have engaged Taproot to process all of our cannabis biomass and sell it to local dispensaries in revenue-share model. This will bring in some needed operating capital within the next 60 days. Our first harvest under the new lights and living soil platform is drying in the cure room and will be ready for sale within the next two to three weeks.
    Our downstream retail relationships are still in great shape. I visited with 10 of the most popular retail dispensaries in Las Vegas and all of them are very familiar with our Fiore brand of premium, top-shelf flower. They all asked when the next lots would be up for sale and we are already booking preorders. High demand for our organic, high THC flower is very encouraging, which will translate into a greater price-per-pound than the Nevada average. Fiore is such a recognizable brand that we may, in fact, change the name of our company to Fiore Cannabis in the near future.
    Once all the grow rooms are planted for their next harvest, we will turn our attention toward firing up our extraction lab once again to produce concentrates and vape pens under our Diamante brand. We have already interviewed the extraction artists who will come in to run the lab and will make employment offers once cash flow permits. For the most part, we will source local B-grade cannabis biomass to convert using our lab in order to take our flower direct to market under the Fiore brand. Cannabis biomass can be purchased relatively cheap and we can also enter into toll extraction contracts where we pay nothing up front and then share in the sale proceeds. It is a very profitable model and we expect to have the lab running 24-seven by the second half of 2021.
    With 7.2 acres of land at Apex, we have plenty of room to expand operations (up to eight to 10 times our current footprint). We have begun the process of seeking proposals and engineering assessments to plan for future growth.
    We have also entered into discussions pertaining to acquiring our own retail dispensary in Las Vegas. A few stores have come upon tough times due to COVID-19 and we believe there will be several opportunities to explore over the coming months.
    Average yields for the Apex facility have been approximately 80 pounds per month with the potential to grow to 150 pounds/month once the facility is fully optimized.
    We also have two cultivation licences assigned to this property (PhenoFarm and EcoNevada) and we are actively looking to sell one licence now that the moratorium on transferring licences in Nevada has ended.

 

Desert Hot Springs -- California

 

  • Our dispensary, Green Leaf Wellness (GLW), remained open throughout the immediate period of COVID-19 lockdown and actually saw a spike in sales throughout Q1. Over all, sales at GLW have increased 15 per cent since April 1, which is largely due to cannabis being deemed an essential service in California.
    In addition to our sales floor remaining open, GLW also opened an express window for pickup and just recently launched a delivery service throughout the Coachella Valley. Both service enhancements were very well received by patients and customers alike.
    Our rating on WeedMaps continues to shine at 4.7/5 and we also added some new signage and storefront imagery to attract attention.
    We have two parcels of land in DHS that we have been approved for CUP extensions of 10 years each. We can develop this land to bring 40,000 square feet of cultivation and production.
    Our staff has implemented a rigorous cleaning and sanitization protocol to exceed government standards related to combating COVID-19. We are happy to report that everyone is healthy and happy to be working every day at the dispensary.

 

Overall state of the nation

As I mentioned when I wrote to introduce myself in March, open communication is very important to me and I am committed to ensuring that investors, employees and the market are always aware of our activities, challenges and accomplishments. I could not be happier with our management team at head office as well as our operating teams in Nevada and California. We have substantially upgraded the talent of our work force by targeting to hire only the best in each respective jurisdiction. I would like to thank everyone for their tireless efforts to help turn the company around, working many late nights and weekends to help push Citation forward.

As we head into the final few months of 2020, I would be happy to take your questions and/or discuss the finer details of our strategy with you at any time. Over the next few weeks, we will schedule an on-line question-and-answer session similar to the one we conducted in March. Please stay tuned for details; in the meantime, you may also e-mail any comments or questions to IR@citationgrowth.com and we will respond quickly.

About Citation Growth Corp.

Citation Growth is a publicly traded company that has been investing in the development of medical and recreational cannabis products since 2014. Citation has expanded its operating portfolio to include cultivation, production and retail offerings in the company's key North American legal jurisdictions Nevada, California, Washington and British Columbia.

We seek Safe Harbor.

FIORF
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PostSubject
#6936  Sticky Note Please read this BOARD WARNING before you submit IH Admin [Tisha] 01/04/20 08:15:18 AM
#7783   CEO hinted at good news coming by months fignewton 04/13/21 03:31:11 AM
#7782   Kind of surprised they only got $1M or fignewton 03/06/21 06:41:27 AM
#7781   Because you know livetom 03/05/21 12:20:20 PM
#7780   More news!! coyoteugly22 03/02/21 09:22:46 AM
#7779   Check out the latest video from Erik Anderson coyoteugly22 02/25/21 10:41:45 AM
#7778   January looked good. Great NR today. coyoteugly22 02/09/21 09:22:49 AM
#7777   It's January. If they start being cash coyoteugly22 02/04/21 12:46:27 PM
#7776   No surprises guys. CEO said cashflow positive coyoteugly22 02/04/21 12:45:10 PM
#7775   Nothin that’s why nothing is happening the new MTJVH 02/03/21 09:41:03 AM
#7774   I'll admit I was surprised to see the fignewton 01/24/21 04:50:05 AM
#7773   Are you the new pump they hired? This Srmadison 01/23/21 11:51:50 AM
#7772   Great piece about the company. Follow their coyoteugly22 01/22/21 11:21:45 AM
#7771   Still holding my bag of shares. Maybe they fignewton 01/16/21 05:44:37 AM
#7770   Nice. livetom 01/14/21 12:47:51 PM
#7769   Wow, things must be looking up as the coyoteugly22 01/14/21 11:58:25 AM
#7768   Guess who's back. Whats up Sav? Where is livetom 01/14/21 11:52:03 AM
#7767   LMAO, I can't believe this scam is still trading. sav79 01/14/21 08:10:17 AM
#7766   Everyone look at the last buy order. 100 livetom 01/13/21 07:07:40 PM
#7765   Everyone look at the last buy order. 100 livetom 01/13/21 07:00:43 PM
#7764   I like the updates. Sure sucks that the livetom 01/13/21 12:58:50 PM
#7763   Great Video showing what is happening. Prior coyoteugly22 01/05/21 10:11:57 AM
#7762   Great article in the Canadian media today!! coyoteugly22 12/17/20 01:23:02 PM
#7761   Citation Growth Corp., CGOTF, changed to Fiore Cannabais Renee 11/09/20 04:38:20 PM
#7760   Thanks for the post. Like the name change, fignewton 11/09/20 12:14:51 PM
#7759   So, I picked up the phone and chatted coyoteugly22 11/09/20 10:48:03 AM
#7758   As well, the company is growing in "Organic coyoteugly22 11/09/20 10:27:41 AM
#7756   Haha So the company has organic cannabis "strains"? J-D 11/05/20 02:44:17 PM
#7755   Citation Growth Corp. Announces Name Change coyoteugly22 11/05/20 09:25:33 AM
#7754   Oh J-D you are funny. All 5 coyoteugly22 10/30/20 09:43:48 AM
#7753   I'm sure you are 100% correct. livetom 10/29/20 01:32:37 PM
#7752   LiveTom If you think Linda and Brian were con J-D 10/29/20 12:46:53 PM
#7751   Got to admit it looks a little funny. livetom 10/28/20 05:12:59 PM
#7750   livetom 10/28/20 05:11:46 PM
#7749   livetom 10/28/20 05:10:29 PM
#7748   I am not an insider, however, if you coyoteugly22 10/28/20 11:49:46 AM
#7747   Well you must be an insider...to have all J-D 10/27/20 07:57:48 PM
#7746   You are funny, the hits keep coming. coyoteugly22 10/20/20 12:43:50 PM
#7745   Well you must live in Vegas or be coyoteugly22 10/20/20 12:42:23 PM
#7744   Wow J-D did you lose money? Can coyoteugly22 10/20/20 12:38:18 PM
#7743   Lost cause J-D 10/18/20 05:34:10 PM
#7742   CEO Letter J-D 10/17/20 04:47:11 AM
#7741   https://www.newsfilecorp.com/release/65968/Citation-Growth-Corp.-Releases-Letter greenwillow 10/15/20 07:15:51 AM
#7739   Warrant Shares NoKneeJerkReactions 10/07/20 07:43:33 PM
#7737   This trash is still trading? Figured it would sav79 09/17/20 11:24:35 PM
#7736   My guess is this has something to do cgessler 09/07/20 06:57:10 AM
#7735   Milestones Annual report ending MAR 31 2020 expected SEP 12 fignewton 09/01/20 04:57:19 AM
#7734   Look like someone knows somthing we don't. livetom 08/31/20 11:28:19 AM
#7733   No more Celista. No more Chase. No more fignewton 08/26/20 09:01:36 AM
#7732   Huhn probably got his golden parachute, since he J-D 08/03/20 12:18:30 PM
#7731   Im talking about Mr Marcel LeBlanc. livetom 07/29/20 11:54:23 AM
PostSubject
Consent Preferences